Publication | Closed Access
LGK974, a PORCUPINE inhibitor, mitigates cytotoxicity in an in vitro model of Parkinson’s disease by interfering with the WNT/β-CATENIN pathway
14
Citations
25
References
2018
Year
Porcupine InhibitorNeurodegenerative DiseasesMedicineParkinson ’Experimental TherapeuticNeuropharmacologyDegenerative PathologyPharmacotherapyNeuroprotectionPharmacologyCell BiologyWnt/β-catenin Pathway
| Year | Citations | |
|---|---|---|
Page 1
Page 1